Denosumab Raises Hypocalcemia Risk in Chronic Kidney Disease ...Middle East

Medscape - News
The risk for emergently treated hypocalcemia in individuals receiving denosumab peaked at 2 weeks after administration and returned to its baseline level by around 10 weeks. Medscape Medical News

Hence then, the article about denosumab raises hypocalcemia risk in chronic kidney disease was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Denosumab Raises Hypocalcemia Risk in Chronic Kidney Disease )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News


Latest News